Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Research & Development readings, the most recent being $345.0 million for Q1 2026.

  • On a quarterly basis, Research & Development changed 0.29% to $345.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 5.18% decrease, with the full-year FY2025 number at $1.3 billion, down 3.89% from a year prior.
  • Research & Development hit $345.0 million in Q1 2026 for GE HealthCare Technologies, up from $323.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $345.0 million in Q1 2026 to a low of $238.0 million in Q1 2022.
  • Median Research & Development over the past 5 years was $315.0 million (2023), compared with a mean of $302.8 million.
  • Biggest five-year swings in Research & Development: rose 23.85% in 2023 and later dropped 7.65% in 2025.
  • GE HealthCare Technologies' Research & Development stood at $271.0 million in 2022, then grew by 16.24% to $315.0 million in 2023, then grew by 9.21% to $344.0 million in 2024, then fell by 6.1% to $323.0 million in 2025, then rose by 6.81% to $345.0 million in 2026.
  • The last three reported values for Research & Development were $345.0 million (Q1 2026), $323.0 million (Q4 2025), and $292.0 million (Q3 2025) per Business Quant data.